methylprednisolone has been researched along with Nasopharyngeal Carcinoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, J; Chen, M; Li, H; Li, Y; Mu, Y; Tang, Y; Xu, Y; Zhao, H; Zhuo, X | 1 |
| Cai, Z; Hu, W; Huang, X; Li, Y; Rong, X; Tang, Y; Xu, Y; Zheng, D; Zuo, Z | 1 |
| Cai, J; Chen, K; Huang, X; Li, H; Li, Y; Lin, J; Rong, X; Tang, Y; Xie, F; Xu, Y; Yan, M; Zhuo, X | 1 |
| Chen, J; Ou, Z; Tan, L; Wang, Y; Yu, Y; Zhao, Y; Zhou, X | 1 |
| Jacobson, MC; Levin, W; McDowell, LJ | 1 |
| Lam, TC; Leung, TW; Ng, SH; Tung, SY; Wong, FC | 1 |
1 trial(s) available for methylprednisolone and Nasopharyngeal Carcinoma
| Article | Year |
|---|---|
Bevacizumab Monotherapy Reduces Radiation-induced Brain Necrosis in Nasopharyngeal Carcinoma Patients: A Randomized Controlled Trial.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antineoplastic Agents, Immunological; Bevacizumab; Brain; Combined Modality Therapy; Female; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Necrosis; Patient Safety; Radiation Injuries; Recurrence; Treatment Outcome | 2018 |
5 other study(ies) available for methylprednisolone and Nasopharyngeal Carcinoma
| Article | Year |
|---|---|
A radiomics model for predicting the response to methylprednisolone in brain necrosis after radiotherapy for nasopharyngeal carcinoma.
Topics: Brain; Humans; Methylprednisolone; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Necrosis; Radiation Injuries | 2023 |
Comparison between high-dose and low-dose intravenous methylprednisolone therapy in patients with brain necrosis after radiotherapy for nasopharyngeal carcinoma.
Topics: Adult; Aged; Brain; Female; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Necrosis; Radiation Injuries; Retrospective Studies | 2019 |
Methylprednisolone use during radiotherapy extenuates hearing loss in patients with nasopharyngeal carcinoma.
Topics: Adult; Audiometry, Pure-Tone; Carcinoma; Evoked Potentials, Auditory, Brain Stem; Female; Hair Cells, Auditory, Outer; Hearing Loss, Sensorineural; Humans; Male; Methylprednisolone; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neuroprotective Agents; Otoacoustic Emissions, Spontaneous; Prospective Studies | 2016 |
High-dose intravenous steroid regimen for radiation-induced hypoglossal nerve palsy.
Topics: Adult; Carcinoma; Chemoradiotherapy; Deglutition; Deglutition Disorders; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Hypoglossal Nerve Diseases; Infusions, Intravenous; Male; Methylprednisolone; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Radiation Injuries; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Retreatment; Speech Intelligibility; Treatment Outcome | 2017 |
Clinical outcomes of 174 nasopharyngeal carcinoma patients with radiation-induced temporal lobe necrosis.
Topics: Age Factors; Analysis of Variance; Brachytherapy; Carcinoma; Female; Follow-Up Studies; Glucocorticoids; Humans; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Necrosis; Neuroprotective Agents; Prognosis; Retreatment; Risk; Salvage Therapy; Survival Rate; Temporal Lobe; Treatment Outcome | 2012 |